Newborn screening second tier molecular testing is critical for identifying true positives in lysosomal storage diseases and X-linked adrenoleukodystrophy
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI